Concepedia

Tricia Cimms

TC

Statistics

Publications

7

Citations

302

H-Index

7

Active since

2006

Affiliations

Ultragenyx Pharmaceutical (United States)(Current)

University of Minnesota

UCSF Benioff Children's Hospital

Johns Hopkins University

Yale University

Tricia Cimms is an author at Ultragenyx Pharmaceutical (United States) specializing in oncology, hypophosphatemia treatment, and endocrinology.

Publications per year

2006–2023

7

Publications

7

Burosumab for the Treatment of Tumor-Induced Osteomalacia

Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber et al. · Journal of Bone and Mineral Research · 2020 · 179 citations · Full text

Medicine, Endocrinology, Oncology +17

The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII

Raymond Wang, José Francisco da Silva Franco, Jaime López‐Valdez et al. · Molecular Genetics and Metabolism · 2020 · 35 citations · Full text

Life Sciences, Pharmacotherapy, Immunopathology +13

The ORTHO BC-SAT – a satisfaction questionnaire for women using hormonal contraceptives

Hilary H. Colwell, Susan D. Mathias, Tricia Cimms et al. · Quality of Life Research · 2006 · 28 citations

Medicine, Endocrinology, Gynecology +11

Burosumab Improves Patient-Reported Outcomes in Adults With Tumor-Induced Osteomalacia: Mixed-Methods Analysis

Suzanne M. Jan de Beur, Tricia Cimms, Annabel Nixon et al. · Journal of Bone and Mineral Research · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome

Ann Maruri, Dale J. Hamilton, Laila Tabatabai et al. · Bone · 2022 · 17 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

1–5 of 7